ArticleHeliyon2025
Association between magnesium depletion score and Klotho levels among U.S. adults: Findings from NHANES 2007-2016.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Magnesium is a vital mineral that plays a crucial role in various physiological processes, and its imbalance has been associated with many chronic aging-related diseases. Traditional assessment methods are insufficient, and the Magnesium Depletion Score (MDS) has been proposed as a significant indicator. Klotho, a transmembrane protein, is involved in aging regulation and oxidative stress modulation. Despite the shared relevance of MDS and Klotho to aging, their relationship remains unclear. Aims: This study aims to investigate the relationship between MDS and Klotho levels in U.S. adults. Methods: We performed a cross-sectional analysis utilizing information from the NHANES database (2007-2016), including 8285 participants. MDS was computed according to specific criteria, encompassing alcohol intake, proton pump inhibitor utilization, diuretic utilization, and renal function. Participants were categorized into groups according to MDS score: none to low (score = 0 or 1), medium (score = 2), and high (score >2). The association between MDS and Klotho levels was assessed using weighted multivariable linear regression models and subgroup analysis. Results: The analysis revealed a negative association between MDS and serum Klotho levels after comprehensive adjustment. Participants with the highest MDS showed decreased Klotho concentrations compared to those with the lowest level. This association remained robust even after excluding outliers. Subgroup analysis indicated a stronger correlation between MDS and serum Klotho concentration in individuals aged 40-60 years, women, and those with normal weight. Conclusion: The findings suggest a negative association between MDS and Klotho levels, indicating that magnesium metabolism may influence Klotho expression. These results underscore the potential significance of magnesium in aging processes and age-related diseases, highlighting the potential benefit of increasing serum Klotho concentration through magnesium supplementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.